• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲炎症性肠病患者静脉血栓栓塞风险:一项全国性队列研究。

Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study.

机构信息

Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

Statistics and Data Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Sci Rep. 2021 Jan 21;11(1):2025. doi: 10.1038/s41598-021-81657-y.

DOI:10.1038/s41598-021-81657-y
PMID:33479464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7820465/
Abstract

Routine prophylaxis for venous thromboembolism (VTE) in Asian IBD patients has been controversial. We aimed to estimate the risk of VTE of Asian patients at different phases of IBD by incorporating patient-specific risk factors. In this cohort study, we analyzed the National Health Insurance claims data between 2012 and 2016 for the entire Korean population. We calculated incidence rates and hazard ratios for VTE. The overall VTE risk was higher in patients with IBD [adjusted hazard ratio (aHR), 2.06; 95% confidence interval (CI), 1.66-2.55], than in controls. When we compare the risk of VTE by different disease phases, the risk of VTE was the highest during post-operation period after IBD-related bowel surgery (aHR, 39.7; 95% CI 9.87-159.3), followed by during hospitalized periods with flare (aHR, 27.2; 95% CI 14.9-49.65) and during hospitalized periods with non-flare (aHR, 16.23; 95% CI 10.71-24.58). The incidence rate (per 1000 person-years) was 15.26 during hospitalized periods with a flare and 9.83 during hospitalized periods with non-flare. According to age groups, the incidence rate (per 1000 person-years) during hospitalized periods with flare was 14.53 in young patients (20-39 years) and 34.58 in older patients (60-80 years). During hospitalized periods with non-flare, the incidence rate was 3.55 in young patients and 23.61 in older patients. The prophylaxis of VTE for Asian patients with IBD should be recommended in older patients admitted to hospital and be considered in young patients who are hospitalized with a flare.

摘要

亚洲炎症性肠病患者常规进行静脉血栓栓塞症(VTE)预防存在争议。我们旨在纳入患者特定的危险因素,以评估不同疾病阶段亚洲患者的 VTE 风险。在这项队列研究中,我们分析了 2012 年至 2016 年期间韩国全民健康保险索赔数据。我们计算了 VTE 的发病率和风险比。与对照组相比,炎症性肠病患者的总体 VTE 风险更高[校正风险比(aHR),2.06;95%置信区间(CI),1.66-2.55]。当我们比较不同疾病阶段的 VTE 风险时,IBD 相关肠道手术后的术后时期 VTE 风险最高(aHR,39.7;95%CI 9.87-159.3),其次是住院缓解期(aHR,27.2;95%CI 14.9-49.65)和住院非缓解期(aHR,16.23;95%CI 10.71-24.58)。有缓解症状的住院期间的发病率(每 1000 人年)为 15.26,无缓解症状的住院期间的发病率为 9.83。按年龄组划分,有缓解症状的住院期间的发病率(每 1000 人年)在年轻患者(20-39 岁)中为 14.53,在老年患者(60-80 岁)中为 34.58。在无缓解症状的住院期间,年轻患者的发病率为 3.55,老年患者为 23.61。应建议对住院的老年亚洲炎症性肠病患者进行 VTE 预防,并考虑对有缓解症状住院的年轻患者进行预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4893/7820465/ae54aa76d366/41598_2021_81657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4893/7820465/53038d189f57/41598_2021_81657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4893/7820465/ae54aa76d366/41598_2021_81657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4893/7820465/53038d189f57/41598_2021_81657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4893/7820465/ae54aa76d366/41598_2021_81657_Fig2_HTML.jpg

相似文献

1
Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study.亚洲炎症性肠病患者静脉血栓栓塞风险:一项全国性队列研究。
Sci Rep. 2021 Jan 21;11(1):2025. doi: 10.1038/s41598-021-81657-y.
2
Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.亚洲炎症性肠病患者的静脉血栓栓塞风险:一项基于人群的全国性发病队列研究。
Gut Liver. 2022 Jul 15;16(4):555-566. doi: 10.5009/gnl210190. Epub 2021 Nov 18.
3
Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.住院的急性炎症性肠病发作患者对血栓预防的认识不足与静脉血栓栓塞症发生率低有关。
Minerva Med. 2020 Dec;111(6):560-565. doi: 10.23736/S0026-4806.20.06885-8. Epub 2020 Jul 28.
4
Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.炎症性肠病东亚患者血栓栓塞事件的发生率和风险因素分析:一项多国合作研究。
Inflamm Bowel Dis. 2018 Jul 12;24(8):1791-1800. doi: 10.1093/ibd/izy058.
5
Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period.妊娠和产后期间的炎症性肠病和静脉血栓栓塞症。
J Thromb Haemost. 2017 Apr;15(4):702-708. doi: 10.1111/jth.13638. Epub 2017 Feb 24.
6
Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.炎症性肠病是复发性静脉血栓栓塞的一个危险因素。
Gastroenterology. 2010 Sep;139(3):779-87, 787.e1. doi: 10.1053/j.gastro.2010.05.026. Epub 2010 Jun 12.
7
An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients.电子警报系统与住院炎症性肠病患者药物性静脉血栓栓塞预防率的显著提高相关。
J Healthc Qual. 2017 Sep/Oct;39(5):307-314. doi: 10.1097/JHQ.0000000000000021.
8
Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line.儿童炎症性肠病患者中心静脉置管住院期间的静脉血栓栓塞症预防。
J Pediatr Gastroenterol Nutr. 2023 May 1;76(5):610-615. doi: 10.1097/MPG.0000000000003747. Epub 2023 Feb 22.
9
Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.住院炎症性肠病患者静脉血栓栓塞症预防的预测因素和安全性。
J Crohns Colitis. 2013 Nov;7(10):e479-85. doi: 10.1016/j.crohns.2013.03.002. Epub 2013 Mar 26.
10
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.血栓预防与炎症性肠病患者住院后静脉血栓栓塞事件的减少有关。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1905-10. doi: 10.1016/j.cgh.2014.02.034. Epub 2014 Mar 12.

引用本文的文献

1
Clots in colitis: Thromboembolism and beyond.结肠炎中的血栓形成:血栓栓塞及其他相关问题。
World J Clin Cases. 2025 Sep 16;13(26):102957. doi: 10.12998/wjcc.v13.i26.102957.
2
Spectrum of venous thromboembolism in adult patients with ulcerative colitis in Pakistan: A single center retrospective study.巴基斯坦成年溃疡性结肠炎患者静脉血栓栓塞的谱:一项单中心回顾性研究。
World J Clin Cases. 2025 Feb 26;13(6):99648. doi: 10.12998/wjcc.v13.i6.99648.
3
Fibrinogen, FDP and D-Dimer as Potential Biomarkers for Disease Severity in Ulcerative Colitis: A Retrospective Study.

本文引用的文献

1
Effect of Cotinine-Verified Change in Smoking Status on Risk of Metachronous Colorectal Neoplasia After Polypectomy.基于可替宁验证的吸烟状态改变对息肉切除术后结直肠腺瘤复发风险的影响。
Clin Gastroenterol Hepatol. 2020 Jan;18(1):163-170. doi: 10.1016/j.cgh.2019.02.018. Epub 2019 Feb 14.
2
The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.炎症性肠病患者静脉血栓栓塞症的发生率及危险因素:一项前瞻性多中心队列研究。
Digestion. 2019;100(4):229-237. doi: 10.1159/000495289. Epub 2018 Dec 14.
3
Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study.
纤维蛋白原、纤维蛋白降解产物和D-二聚体作为溃疡性结肠炎疾病严重程度的潜在生物标志物:一项回顾性研究
Int J Gen Med. 2024 Nov 26;17:5573-5579. doi: 10.2147/IJGM.S477285. eCollection 2024.
4
Perioperative optimization of Crohn's disease.克罗恩病的围手术期优化
Ann Gastroenterol Surg. 2022 Oct 13;7(1):10-26. doi: 10.1002/ags3.12621. eCollection 2023 Jan.
5
Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview.炎症性肠病患者的血栓栓塞事件:全面概述
Diseases. 2022 Sep 30;10(4):73. doi: 10.3390/diseases10040073.
6
Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?东亚炎症性肠病患者发生静脉血栓栓塞的风险与西方患者相当吗?
Gut Liver. 2022 Jul 15;16(4):495-496. doi: 10.5009/gnl220279.
7
Cerebral venous sinus thrombosis in patients with inflammatory bowel disease: a retrospective study.炎症性肠病患者的脑静脉窦血栓形成:一项回顾性研究。
Sci Rep. 2021 Aug 20;11(1):17004. doi: 10.1038/s41598-021-96541-y.
韩国炎症性肠病的新兴趋势:一项全国范围内基于人群的研究。
J Gastroenterol Hepatol. 2019 Jun;34(6):1018-1026. doi: 10.1111/jgh.14542. Epub 2018 Dec 10.
4
The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study.日本炎症性肠病住院患者静脉血栓栓塞的发病率及危险因素:一项回顾性队列研究
Intest Res. 2018 Jul;16(3):416-425. doi: 10.5217/ir.2018.16.3.416. Epub 2018 Jul 27.
5
Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study.炎症性肠病东亚患者血栓栓塞事件的发生率和风险因素分析:一项多国合作研究。
Inflamm Bowel Dis. 2018 Jul 12;24(8):1791-1800. doi: 10.1093/ibd/izy058.
6
Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.亚洲炎症性肠病的医疗质量:在首尔举行的第二届亚洲克罗恩病和结肠炎组织(AOCC)会议上进行的一项跨国网络调查结果
Intest Res. 2016 Jul;14(3):240-7. doi: 10.5217/ir.2016.14.3.240. Epub 2016 Jun 27.
7
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.首部关于炎症性肠病肠外表现的欧洲循证共识
J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27.
8
Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study.2006 - 2012年韩国炎症性肠病的发病率及自然病程:一项基于全国人口的研究
Inflamm Bowel Dis. 2015 Mar;21(3):623-30. doi: 10.1097/MIB.0000000000000313.
9
Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.炎症性肠病增加住院患者深静脉血栓形成和肺栓塞的风险:一项全国性队列研究。
Thromb Res. 2015 Mar;135(3):492-6. doi: 10.1016/j.thromres.2014.12.025. Epub 2015 Jan 7.
10
Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES).数据资源简介:韩国国家健康与营养检查调查(KNHANES)
Int J Epidemiol. 2014 Feb;43(1):69-77. doi: 10.1093/ije/dyt228.